<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1069</ReferenceId>
        <DateLastUpdated>2018-10-16-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11432818</PubmedId>
            <Abstract>The three-dimensional structure of a bacterial superantigen, Staphylococcus aureus enterotoxin H (SEH), bound to human major histocompatibility complex (MHC) class II (HLA-DR1) has been determined by X-ray crystallography to 2.6 A resolution (1HXY). The superantigen binds on top of HLA-DR1 in a completely different way from earlier co-crystallized superantigens from S.aureus. SEH interacts with high affinity through a zinc ion with the beta1 chain of HLA-DR1 and also with the peptide presented by HLA-DR1. The structure suggests that all superantigens interacting with MHC class II in a zinc-dependent manner present the superantigen in a common way. This suggests a new model for ternary complex formation with the T-cell receptor (TCR), in which a contact between the TCR and the MHC class II is unlikely.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>3306-12</ArticlePages>
            <ArticleTitle>Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Petersson</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Håkansson</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Nilsson</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Forsberg</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Svensson</LastName>
                    <ForeName>L A</ForeName>
                </Author>
                <Author>
                    <LastName>Liljas</LastName>
                    <ForeName>A</ForeName>
                </Author>
                <Author>
                    <LastName>Walse</LastName>
                    <ForeName>B</ForeName>
                </Author>
            </Authors>
            <Affiliations>Molecular Biophysics, Centre for Chemistry and Chemical Engineering, Lund University, PO Box 124, S-221 00 Lund, Sweden.</Affiliations>
            <ArticleChemicalList>Enterotoxins;HLA-DR1 Antigen;Recombinant Proteins;Staphylococcal enterotoxin H;Superantigens;Zinc</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Binding Sites; Cloning, Molecular; Crystallography, X-Ray(methods); Enterotoxins(chemistry; immunology); HLA-DR1 Antigen(chemistry); Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins(chemistry; immunology); Sequence Alignment; Sequence Homology, Amino Acid; Staphylococcus aureus; Superantigens(chemistry; immunology); Zinc(chemistry); Zinc Fingers</ArticleMeshHeadingsList>
            <Journal>
                <Volume>20</Volume>
                <Issue>13</Issue>
                <Title>The EMBO journal</Title>
                <Issn>0261-4189</Issn>
                <MedlineTa>EMBO J</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HA (306-318)</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PKYVKQNTLKLAT</LinearSequence>
                        <StartingPosition>306</StartingPosition>
                        <EndingPosition>318</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>0704243A</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11320</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>48237</EpitopeId>
                <ReferenceStartingPosition>306</ReferenceStartingPosition>
                <ReferenceEndingPosition>318</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <MhcBindingId>1488356</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>175</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>2.6</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The crystal structure contains the MHC/epitope complex bound to the superantigen (SAG) staphylococcal enterotoxin type H (SEH). SAG PDB chain is D. Residues that had a well ordered electron density and were included in the final model are: MHC chain α (PDB chain A) residues 3-182; MHC chain β (PDB chain B) residues 3-103, 112-190; epitope (PDB chain C) residues 306-318; SAG (PDB chain D) residues 2-213.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>46</MhcAlleleId>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1HXY</ComplexPdbId>
                            <MhcChain1PdbChain>A</MhcChain1PdbChain>
                            <MhcChain2PdbChain>B</MhcChain2PdbChain>
                            <EpitopePdbChain>C</EpitopePdbChain>
                            <EpitopeResidues>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317, T318;</EpitopeResidues>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>[| P-2: P306; P-1: K307; P1: Y308; P2: V309; P3: K310; P4: Q311; P5: N312; P6: T313; P7: L314; P8: K315; P9: L316; P10: A317; P11: T318; |] The SAG molecule binds to the b1 helix of the MHC molecule. It also makes van der Waal's interactions with the main chain of the N-terminal part of the epitope, from residue P-1: K307 to P3: K310. The SAG molecule actually covers almost half of the epitope-binding groove on the MHC molecule. Only minor conformational changes were observed on the MHC molecule and the epitope, upon binding of the SAG molecule to the MHC/epitope complex in comparison with HLA-DR1-HA-peptide complex [PDB: 1DLH]. The only important changes are located at the side chains of MHC residues A: E55, Q57; that are repositioned in order to be able to make van der Waal’s contacts with the SAG molecule.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317, T318;</EpitopeResidues>
                                <EpitopeResiduesInteractingWithMhc>C: ;</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: ; B: ;</MhcResiduesInteractingWithEpitope>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResiduesInteractingWithMhc>C: P306, K307, Y308, V309, K310, Q311, N312, T313, L314, K315, L316, A317</EpitopeResiduesInteractingWithMhc>
                                <MhcResiduesInteractingWithEpitope>A: Q9, E11, F24, I31, F32, W43, F51, A52, S53, F54, G58, N62, V65, D66, N69, I72, M73, R76; B: W9, L11, F13, E28, Y47, P56, D57, Y60, W61, L67, Q70, R71, A74, Y78, H81, N82, V85, G86, F89</MhcResiduesInteractingWithEpitope>
                                <ContactAreaForEpitope>1314.0</ContactAreaForEpitope>
                                <ContactAreaForMhc>907.3</ContactAreaForMhc>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

